PT3148990T - Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação - Google Patents
Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamaçãoInfo
- Publication number
- PT3148990T PT3148990T PT157250424T PT15725042T PT3148990T PT 3148990 T PT3148990 T PT 3148990T PT 157250424 T PT157250424 T PT 157250424T PT 15725042 T PT15725042 T PT 15725042T PT 3148990 T PT3148990 T PT 3148990T
- Authority
- PT
- Portugal
- Prior art keywords
- psychiatric
- inflammation
- treatment
- neurological disorders
- thiazolidinone compounds
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000003959 neuroinflammation Effects 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14171024 | 2014-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3148990T true PT3148990T (pt) | 2022-05-02 |
Family
ID=50841700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157250424T PT3148990T (pt) | 2014-06-03 | 2015-05-28 | Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação |
Country Status (1)
| Country | Link |
|---|---|
| PT (1) | PT3148990T (pt) |
-
2015
- 2015-05-28 PT PT157250424T patent/PT3148990T/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
| IL259751B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
| SG11201607705XA (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| IL258032B (en) | Compounds and preparations for the treatment of ocular disorders | |
| PT3160464T (pt) | 6-hidroxibuspirona para uso no tratamento de transtornos do movimento | |
| IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
| IL246855A0 (en) | Materials for use in the treatment of retinitis | |
| IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
| EP3371154A4 (en) | HETEROCYCLIC DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS | |
| HRP20220490T8 (hr) | Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
| GB201603510D0 (en) | Compositions for use in the treatment of neurological disease | |
| PT3442537T (pt) | (+)-azasetrom para utilização no tratamento de doenças do ouvido | |
| HK1260601A1 (en) | Heterocycle derivatives and their use for the treatment of cns disorders | |
| PT3370727T (pt) | Derivados da pregnenolona substituídos em c3 não bioconvertíveis para utilização no tratamento de distúrbios de toxicodependência |